Advertisement
Explore the most exciting new ideas and emerging concepts in science, health, technology and the environment with Â鶹´«Ã½â€™s exclusive in-depth articles, interviews and long reads.
From the rotation of galaxies to cosmic expansion everything points in one direction. If only we knew why
Six years ago, Randy Hillard was diagnosed with terminal gastric cancer and given less than a year to live. But then he responded extraordinarily well to the drug trastuzumab (Herceptin) – originally meant to extend his life by two months. Six years later, he is still having $17,000 infusions every three weeks. His survival has cost $1.6 million – and counting. A professor of psychiatry at Michigan State University and a hospice doctor, Hillard knows it is a high price to pay. He spoke to Â鶹´«Ã½ during his 95th Herceptin infusion.